Genus PLC (LON:GNS) Rating Reaffirmed
Liberum Capital now has a GBX 1500.00 target price on shares of Genus PLC (LON:GNS). The target price would indicate a potential upside of 1.15% from the closing share price of Genus PLC (LON:GNS). This rating was revealed to clients and investors in analysts note on Monday morning.
From a total of 5 analysts covering Genus PLC (LON:GNS) stock, 2 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 40% of the ratings are positive. The highest target price is GBX 1550 while the lowest target price is GBX 1426. The mean of all analyst targets is GBX 1488.6 with a 0.51% above today’s (GBX 1481) stock price. Genus PLC was the topic of 21 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. N+1 Singer maintained shares on November 19 with “Hold” rating. Peel Hunt maintained GNS stock in a recent report from November 19 with “Buy” rating. Finally, Numis Securities maintained the stock with “Hold” rating in a report issued on a September 8.
Approximately 1,867 shares of stock traded hands. Genus plc (LON:GNS) has risen 2.88% since May 8, 2015 and is uptrending. It has outperformed by 3.96% the S&P500.
Genus plc is a United Kingdom-based animal genetics company. The company has a market cap of 908.63 million GBP. The Firm provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. It has 22.81 P/E ratio. The Company’s divisions are Genus PIC, Genus ABS and Genus Asia.